Halothane metabolism in children

Area of Science:

• Anesthesiology
• Pediatric Pharmacology
• Clinical Chemistry

Background:

• Halothane is a volatile anesthetic agent used in pediatric anesthesia.
• Halothane-associated hepatitis is a known complication, with a higher incidence reported in children.
• Understanding halothane metabolism in children is crucial for assessing risks.

Purpose of the Study:

• To quantitatively assess halothane uptake and elimination in children.
• To measure the urinary excretion of halothane metabolites (trifluoroacetic acid, fluoride) in pediatric patients.
• To compare the metabolic pathways of halothane in children with those in adults.

Main Methods:

• Administered 1% halothane to six children (mean age 74 months) for 60 minutes.
• Measured halothane uptake via inspired and expired gas analysis.
• Monitored halothane elimination in expired gas post-administration.
• Analyzed urinary excretion of trifluoroacetic acid and inorganic fluoride for up to one week.

Main Results:

• Halothane uptake varied from 176 to 310 mg kg-1, influenced by minute ventilation.
• 32-37% of absorbed halothane was eliminated in expired gas within 90 minutes.
• 11.4% of absorbed halothane was excreted as trifluoroacetic acid and 0.37% as inorganic fluoride in urine.
• Urinary half-life of trifluoroacetic acid was approximately 41.8 hours.

Conclusions:

• The quantitative and qualitative metabolism of halothane in children is comparable to adults.
• No significant differences in halothane metabolism were identified that could explain the higher hepatitis incidence in children.
• Further research may be needed to elucidate the reasons for increased halothane-associated hepatitis in pediatric populations.